Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA
25/03/2026 15:26
March 25 (Reuters) - Lee's Pharmaceutical 0950.HK: APPROVAL OF INTRAROSA BY NMPA ON 17 MARCH NMPA GRANTED APPROVAL FOR COSETTE PHARMACEUTICALS' INTRAROSA Further company coverage: 0950.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA